Skip to content
Search AI Powered

Latest Stories

Pharmacists' role in Fit Note Certification sees modest uptake, NHS data reveals

Pharmacists' role in Fit Note Certification sees modest uptake, NHS data reveals
A total of 1.4 per cent of the fit note seekers relied on pharmacists to issue them the certification

Recent NHS data sheds light on the evolving landscape of fit note certification, indicating a gradual expansion of roles beyond traditional medical practitioners to pharmacists and nurses.

This uptake in numbers coincides with the Department of Work and Pensions's (DWP) call for evidence in relation to fit note reform which will remain open till 8 July 2024.


According to figures published by NHS Digital, during the nine-month period from April 2023 to December 2023, pharmacists certified a significant number of fit notes.

Approximately 1.4 per cent of fit notes of the 8 million were issued by pharmacists while the rest were issued by the GP surgeries reflecting the impact following legislative amendments in July 2022, which extended certification authority to pharmacists, nurses, occupational therapists, and physiotherapists.

In June 2022, the Pharmacists' Defence Association (PDA) advised pharmacists not to sign fit notes where the required therapeutic, diagnostic, or examination skills lie outside their scope of competence.

The association remarked that healthcare professionals needed mandatory training under the Health Education England before they are fit to issue fitness notes to the public.

The data also highlights a substantial reliance on doctors for fit note certification, with 91.3 per cent of fit notes being certified by medical practitioners during the same period.

Similarly, nurses accounted for 6.7 per cent of certifications, followed by physiotherapists at 0.6 per cent, and occupational therapists at 0.03 per cent.

Despite the regulatory changes aimed at diversifying certification sources, the uptake by non-doctor healthcare professionals remains modest, with only 8.4 per cent of fit notes issued by these professionals between April and September 2023.

In response to the observed low uptake, the Department for Work and Pensions (DWP) has initiated efforts to bolster awareness and utilization of the expanded certification framework.

This includes the publication of updated fit note guidance in October 2023, aimed at healthcare professionals, employers, and employees.

The call for evidence, launched by the DWP, seeks to gather insights to inform further reforms in the fit note process.

The government's commitment to enhancing the fit note system was outlined in the 2023 autumn statement, where plans for end-to-end reforms were proposed to support individuals in resuming work following periods of illness.

These reforms aim to streamline the fit note process, ensuring timely access to specialized work and health support while freeing up valuable time for healthcare professionals.

While the uptake of non-doctor certifications remains a focal point, the data underscores a gradual shift towards a more diversified approach in fit note issuance with pharmacists playing an increasingly significant role, alongside other healthcare professionals to better meet the needs of patients and employers alike.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less